期刊文献+

微RNA在胰腺癌诊断及治疗中的研究进展 被引量:1

Advanced Research in MicroRNA in Pancreatic Adenocarcinoma Diagnosis and Treatment
下载PDF
导出
摘要 胰腺癌是常见的恶性程度较高的消化道肿瘤,除手术切除外缺少有效的治疗手段,患者5年内生存率<5%。微RNA(miRNAs)家族在分子层面影响着RNA-RNA的相互作用,miRNA在转录后水平对细胞的代谢、生长、分化、增殖、凋亡发挥着重要作用,这种对细胞的作用同样存在于肿瘤细胞中。近几年来已发现20种以上的miRNAs,在胰腺癌的生物学行为、发生发展、转移以及化疗的敏感性中的表达存在差异。 Pancreatic cancer is a common and malignant gastrointestinal tumor,which is lack of effective treatment besides surgery,5 years survival rate is less than 5%.MicroRNAs are molecules influencing RNA-RNA interaction,performing a regulatory role in the metabolism,development,differentiation,proliferation and apoptosis of normal cells,as well as in carcinogenesis.More than 20 microRNAs have been identified, being involved in pancreatic adenocarcinoma biology,affecting tumor growth,metastatic potential,and chemo-therapy sensitivity.
出处 《医学综述》 2015年第14期2569-2571,共3页 Medical Recapitulate
关键词 胰腺癌 微RNA 诊断 治疗 Pancreatic adenocarcinoma MicroRNA Diagnosis Ttreatment
  • 相关文献

参考文献27

  • 1Saif MW.Pancreatic cancer:highlights from the 42nd annual meeting of the American Society of Clinical Oncology,2006[J].JOP,2006,7(4):337-348.
  • 2Ni X,Long J,Cen P,et al.Pancreatic cancer tumour initiating cells:the molecular regulation and therapeutic values[J].J Cell Mol Med,2012,16(5):988-994.
  • 3陈万青,王庆生,张思维,郑荣寿,何慧,陈建平,刘卫东.2003-2007年中国胰腺癌发病与死亡分析[J].中国肿瘤,2012,21(4):248-253. 被引量:50
  • 4Siegel R,Ma J,Zou Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29.
  • 5Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15(6):2403-2413.
  • 6Kwak PB,Iwasaki S,Tomari Y.The microRNA pathway and cancer[J].Cancer Sci,2010,101(11):2309-2315.
  • 7Gregory RI,Yan KP,Amuthan G,et al.The Microprocessor complex mediates the genesis of microRNAs[J].Nature,2004,432(7014):235-240.
  • 8Bohnsack MT,Czaplinski K,Gorlich D.Exportin 5 is a Ran GTPdependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs[J].RNA,2004,10(2):185-191.
  • 9Yi R,Qin Y,Macara IG,et al.Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs[J].Genes Dev,2003,17(24):3011-3016.
  • 10Garzon R,Marcucci G,Croce CM.Targeting microRNAs in cancer:rationale,strategies and challenges[J].Nat Rev Drug Discov,2010,9(10):775-789.

二级参考文献99

  • 1施健,吴诚,刘苏,谢渭芬.我国胰腺癌部分发病危险因素的Meta分析[J].胰腺病学,2004,4(3):154-158. 被引量:14
  • 2陈建国,朱健,张永辉.启东市1972~2000年主要恶性肿瘤生存率分析[J].中国肿瘤,2006,15(9):575-578. 被引量:34
  • 3Jemal A, Siegel R, Ward E,et al. Cancer statistics, 2009[J]. CA Cancer J Clin, 2009, 59 (4) : 225 - 249.
  • 4Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure[ J]. Ann Surg, 1987, 206 (3) : 358 - 365.
  • 5Li D, Xie K, Wolff R, et al. Pancreatic cancer [ J]. Lancet, 2004, 363:1049 - 1057.
  • 6Bipat S, Phoa SS, van Delden OM, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta - analysis[ J ]. J Comput Assist Tomogr, 2005, 29 (4) : 438 - 445.
  • 7National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline in Oncology for Pancreatic Adenocarcinoma V [ S ]. 1. 2009.
  • 8Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease[ J]. J Am Coll Surg, 2008, 206 (5) : 833 - 846.
  • 9Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine- based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head[ J]. J Clin Oncol, 2008,26: 3496 - 3502,.
  • 10Gillen S, Schuster T, Meyer ZC, et al. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta- analysis of response and resection percentages[ J]. PLoS Med, 2010, 7 (4): e1000267.

共引文献79

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部